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Abstract 
Three new quinazolinobenzodiazepine derivatives, novobenzomalvins A (1), B 
(2), and C (3), have been isolated as fibronectin expression regulators from 
Aspergillus novofumigatus  CBS117520. The structures of 1  to  3  were 
established by spectroscopic and physicochemical analysis, and chemical 
investigation including the total synthesis of 1.  Treatment with novo-
benzomalvins A (1), B (2), C (3), and N-methylnovobenzomalvin A (5) increased 
the expression of fibronectin in normal human neonatal dermal fibroblast cells.  
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Introduction 
The fungus Aspergillus fumigatus  is known as an important human pathogen, which 
produces  many secondary metabolites. Recently, Hong et al. re-identified the fungus 
Aspergillus novofumigatus CBS11520 as the new Aspergillus sp., which is closely related 
to A. fumigatus [1]. We have previously reported the isolation of two diketopiperazines, 
novoamauromine and ent-cycloechinulin, and a cyclic tripeptide, novofumigatamide, from 
the MeOH extract of this fungus cultivated on rice [2, 3]. Further investigation of this fungal 938  K. Ishikawa et al.:   
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metabolite led to the  isolation of three new quinazolinobenzoziazepine derivatives: 
novobenzomalvins A (1), B (2), and C (3) (Figure 1). This report describes the isolation, 
structure, and biological activity of 1–3. 
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Fig. 1.   Structures of compounds 1–5 
Results and Discussion 
Solid-substrate fermentation cultures of A. novofumigatus CBS117520 grown on rice were 
extracted with MeOH. The evaporated extract was suspended in water and extracted with 
EtOAc. The evaporated extract was partitioned with MeCN and n-hexane to yield a MeCN-
soluble fraction. The fraction was extracted sequentially with n-hexane, benzene, CHCl3, 
EtOAc, and MeOH. The benzene extract was chromatographed on a Sephadex LH-20 
column, followed by medium-pressure liquid column chromatography (MPLC) on silica gel. 
Thin-layer chromatography (TLC) analysis  led to the separation  of  the  compound-
containing fractions. Further purification  of these fractions  by high-performance liquid 
chromatography (HPLC) yielded 1,  2, and 3  along with the known  compounds  epi-
aszonalenin A and C, and helvolic acid [4–7].
 
The molecular formula of 1 was determined to be C23H17N3O2 (17 degrees of unsaturation) 
by high-resolution chemical ionization mass spectrometry (HRCIMS). The presence of NH 
groups was deduced from the broad absorption at  3437 cm
−1  in the compound’s IR 
spectrum. Two carbonyl groups were inferred from its 
13C NMR spectrum (168.7 and 161.4 
ppm) and the absorptions at 1690 and 1665 cm
−1 in its IR spectrum. The presence of a 
quinazolinobenzodiazepine ring with an attached benzyl group on C-19 of its ring were 
deduced from 
1H, 
13C NMR, 
1H 
1H COSY, and HSQC data (Figure 2).    Novobenzomalvins A–C: Fibronectin Expression Regulators from Aspergillus novofumigatus  939 
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Fig. 2.   Selected 
1H 
1H COSY and HMBC correlations of novobenzomalvin A (1) 
These results suggested that the planar structure of 1 was a demethylated metabolite of 
benzomalvin A (4), which was originally isolated from Penicillium spp [8]. However, the 
optical rotation [+145° (c 0.19, MeOH)] of the N-methylated product (5) derived from 1 
[+136° (c 1.09, MeOH)] was clearly different from that of benzomalvin A (4) [−106° (c 1.0, 
MeOH)] [8]. Thus, 1 was presumed to have the R configuration at C-19. To confirm the 
stereochemistry of 1, the compound was synthesized from D-phenylalanine by a modified 
method [9] (Scheme 1), and the optical rotation of the synthetic product (1) was +111° 
(c 0.73, MeOH). From the above results, the chemical structure of 1 was confirmed to be 
identical to those as shown in Figure 1.  
The molecular formula of 2 was found to be C23H17N3O3 by HREIMS. The 
1H and 
13C NMR 
spectra of 2 was similar to those of 1, expect for the downfield shift of the carbon at C-20 
from δ 35.2 in 1 to δ 72.9 in 2 and the new appearance of a methine signal (δ 5.32) in 2 
instead of a methylene signal (δ 3.29 and δ 3.59) in 1 (Table 1). Analysis of the 
1H 
1H 
COSY and HMBC spectra supported the planar structure of 2  being the  20-hydroxy 
derivative of 1 (Figure 2). X-ray crystallographic analysis of novobenzomalvin B (2) was 
performed to confirm the structure, as the crystal of 2 was suitable for X-ray analysis. The 
result established the absolute configuration of 2 as shown in Figure 3 [10], in light of the 
Flack parameter  [11]  of  −0.04(12), using anomalous dispersion of 1263 Friedel pairs 
[12, 13].  
 
Fig. 3.   X-ray crystal structure of novobenzomalvin B (2) with thermal ellipsoids at 50% 
probability 940  K. Ishikawa et al.:   
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Sch. 1.   Total synthesis of novobenzomalvin A (1) 
The molecular formula (C23H15N3O3) of 3 suggested the loss of two protons from that of 2 
(C23H17N3O3) and thus indicated the replacement of a hydroxyl group in 2 with a carbonyl 
group in 3. The 
1H and 
13C NMR spectra of 3 and 2 showed only the difference of a 
carbonyl sp
2 carbon signal (δ 188.9) in 3 instead of a secondary hydroxyl group (δ 72.9, δ 
5.32) in 2 (Table 1). The analysis of the 
1H 
1H COSY, and HMBC spectra supported 3 
having a planar structure as the 20-didehydro derivative of 2, that is, the 20-oxo derivative 
of 1 (Figure 2). Novobenzomalvin C (3) was prepared by treatment of 2 with pyridinium 
chlorochromate (PCC). The optical rotation of 3 derived from 2 was −329° (c 0.14, MeOH), 
whereas that of naturally occurring 3 was −256° (c 0.18, MeOH). Therefore, the absolute 
structure of 3 was determined to be the one shown in Figure 1. 
A wide variety of quinazolinobenzodiazepine alkaloids have been recently reported as 
natural products from several filamentous fungi, for example: sclerotigenin, an anti-insect 
active compound isolated from the sclerotia of Penicillium sclerotigenum [14]; asperlicins 
A–E, potent nonpeptidal  cholecystokinin antagonists  isolated from Aspergillus alliaceus 
[15–17];  benzomalvins,  substance-P inhibitors  isolated from Penicillium  sp.  [8];  and 
circumdatins A–I isolated from Aspergillus ochraceus [18–21] and Exphiala sp. [22]. These 
alkaloids which have been recently reported as natural products consist of two anthranilic   Novobenzomalvins A–C: Fibronectin Expression Regulators from Aspergillus novofumigatus  941 
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acids  and a L-amino acid (e.g., benzomalvin A contains L-phenylalanine, asperlicin C 
contains L-tryptophan, and circumdatin C, F, G, and I contain L-alanine, etc.) and the all 
C-19 configuration of them is the same as that of L-amino acids. Interestingly, the C-19 
configuration of 1–3 is opposite that of other quinazolinobenzodiazepine alkaloids, and this 
fact suggests that the only A. novofumigatus in genus Aspergillus utilized D-amino acid in 
its  biosynthesis.  Therefore,  it  might  be possible to utilize novobenzomalvins  for good 
chemotaxonomic markers of Aspergillus section Fumigati. 
 
Fig. 4.   Effect of novobenzomalvins on expression of fibronectin in NHDF-neo cells.  
a: Normal human neonatal dermal fibroblast (NHDF-neo) cells were incubated 
with novobenzomalvins (each 10 μM), or TGF-β (10 ng/mL) as a positive control 
for 24 h.  
b: NHDF-neo cells were incubated with 0.01, 0.1, 1.0, 5.0, and 10.0 μM 
novobenzomalvins for 24 h. 
We studied effects of novobenzomalvins A (1)–C (3) and N-methylnovobenzomalvin A (5) 
on the expression of fibronectin (FN). Normal human neonatal dermal fibroblast (NHDF-
neo) cells were incubated with novobenzomalvins (each 10 µM), or TGF-β (10 ng/mL) as a 
positive control for 24 h. Treatments of cells with all of the novobenzomalvins increased 
the expression of fibronectin, as well as that of TGF-β  (10 ng/mL) as a positive control 
(Figure 4). Fibronectin is an important ingredient of the extracellular matrix proteins in the 
skin, and is often used as an index for evaluating the extent of matrix accumulation [23]. 
Although previous reports have shown that some alkaloids such as berberine and 
cepharanthine effectively reduced fibronectin protein expression [24, 25], little is known 
about stimulation of fibronectin expression by other alkaloids. In the present study, our 
data revealed that fibronectin increases in NHDF-neo  cultured in the treatment with 
novobenzomalvins, indicating novobenzomalvins could activate the skin function through 
stimulating extracellular matrix accumulation. To our knowledge, this is the first reported 
example that quinazolinobenzodiazepine alkaloids increased the expression of fibronectin. 
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We would like to examine their functional mechanism in future research. In addition, the 
antifungal and cytotoxic activities of 1–3 were studied using a previously reported method 
[26].  1–3  showed  non-specific antifungal activity against four human pathogenic fungi 
(Aspergillus niger, A. fumigatus, Candida albicans, and Cryptococcus neoformans) tested 
at 100 μg per disk, and these compounds did not inhibit the cell proliferation in A549, Hela, 
and LNCap cells at 100 μM.  
Tab. 1.   NMR Spectroscopic Data (400 MHz, CDCl3) for Novobenzomalvins A–C 
  Novobenzomalvin A (1)  Novobenzomalvin B (2) Novobenzomalvin C (3) 
Position  δC  δH (J in Hz)  δC  δH (J in Hz)  δC  δH (J in Hz) 
1-NH    8.70, d, (5.0)         
2  168.7    167.4    165.7   
3  130.6    132.7    130.9   
4  129.8  7.83, d, (7.5)  130.1  7.92. d (7.7)  130.6  8.04, dd (7.7, 1.5) 
5  131.1  7.41, m  131.4  7.61, m  131.7  7.72, ddd  
(8.1, 7.7, 1.5) 
6  128.2  7.54, m  127.0  7.63, m  129.4  7.61, dd (8.1, 7.7) 
7  133.2  7.54, m  129.3 7.55, dd (7.9, 7.2)  128.3  7.80, d (8.1) 
8  133.2    130.4    133.0   
9-NH             
10  161.4    160.9    161.0   
11  120.8    121.4    121.4   
12  126.9  7.91, d (7.9)  127.6  8.21, d (7.9)  127.4  8.29, dd (8.0, 1.3) 
13  127.2  7.26, m  128.3  7.28, m  128.2  7.49, m 
14  134.5  7.51, m  135.1 7.75, dd (7.6, 7.5)  134.9  7.67, ddd  
(8.2, 7.6, 1.3) 
15  127.4  7.45, d (8.1)  128.0  4.48, m  127.8  7.41, d, 8.2) 
16  145.6    145.0    145.7   
17-NH             
18  154.2    154.4    152.8   
19  55.9  4.35, brdd,  
(8.5, 5.4)  57.5  4.46, brdd  
(8.0, 5.5)  58.5  5.82, d (5.5) 
20  35.2 
3.26, dd  
(14.6, 8.5), 
3.59, dd  
(14.6, 5.4) 
72.9  5.32, dd  
(6.9, 5.5)  188.9   
21  137.3    139.0    134.6   
22  129.7  7.33, d  126.7  7.45, d (7.6)  128.5  7.87, d (7.9) 
23  128.5  7.23, m  128.6  7.33, brt (7.2)  128.9  7.46, dd (7.9, 7.7) 
24  126.7  7.18, dd  128.3  7.28, m  134.2  7.59, m 
25  128.5  7.23, m  128.6  7.33, brt (7.2)  128.9  7.46, dd (7.9, 7.7) 
26  129.7  7.33, d  126.7  7.45, d (7.6)  128.5  7.87, d (7.9) 
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Experimental 
General 
Melting points were determined on a micro-melting point apparatus (Yanagimoto Ltd., 
Kyoto,  Japan) and are uncorrected. CI and EIMS data were measured on  a JMS-MS 
600W spectrometer (JEOL Co. Ltd., Tokyo, Japan). UV and IR spectra were recorded on 
an Ultrospec 2100 pro UV–visible spectrophotometer (Amersham Biosciences Ltd., Tokyo, 
Japan) and a FT/IR-4100 instrument (JASCO Co. Ltd., Tokyo, Japan), respectively. 
1H 
and 
13C NMR spectra were recorded using a Bruker AVANCE-400 spectrometer (400.13 
MHz for 
1H, 100.61 MHz for 
13C, Bruker Biospin K. K., Kanagawa, Japan). Chemical shifts 
(δ) were measured in ppm using tetramethylsilane as an internal standard. CD curves 
were determined on a J-820 spectropolarimeter (JASCO Co. Ltd.). Optical rotations were 
measured with a P-1020 photopolarimeter (JASCO Co. Ltd.). TLC was visualized by UV 
light at 254 nm and/or by spraying with phosphomolybdic acid (5%)/ceric acid (trace) in 5% 
H2SO4  and then  heating. Column chromatography was performed using a Sephadex 
LH-20 (GE Healthcare Bio-Science AB, Uppsala, Sweden). MPLC was performed using a 
Chemco Low-Prep  81-M-2 pump (Chemco Scientific Co. Ltd., Osaka, Japan) and an 
ULTRA PACK SI-40B column (300 × 26 mm, Yamazen Corp., Osaka, Japan). HPLC was 
performed using a Senshu SSC-3160 pump (flow rate 7 mL/min, Senshu Scientific Co. 
Ltd., Tokyo, Japan) and a YMCPack PEGASIL Silica 60-5 column (300 × 10 mm, YMC Co. 
Ltd., Kyoto, Japan), equipped with a YRD-883 RI detector (Shimamuratech Ltd., Tokyo, 
Japan). Microwave  irradiation reactions were performed in a microwave synthesizer 
(Initiator 1, Biotage Japan Ltd., Tokyo, Japan). 
Isolation of metabolites from Aspergillus novofumigatus CBS117520 
Polished rice (Akitakomachi, 24 kg) was soaked in water for 30 min and then sterilized with 
an autoclave. A. novofumigatus CBS117520 was cultivated for 14 days in Roux flasks, 
each containing 140 g of moist rice. The cultivated rice was extracted with MeOH, and the 
extract was concentrated in vacuo. The residue was suspended in water and extracted 
with EtOAc. The EtOAc extract (52 g) was partitioned between n-hexane and MeOH to 
yield a MeCN-soluble mixture. The MeCN extract (29.4 g) was extracted sequentially with 
n-hexane, benzene, CHCl3, EtOAc, and MeOH (100 mL each). The benzene extract (18 g) 
was chromatographed on a Sephadex LH-20 column [solvent system:  n-hexane/CHCl3 
(1:4), 180 mL; CHCl3/acetone (3:2), 220 mL; CHCl3/acetone (1:4), 200 mL; acetone, 200 
mL; and  then MeOH, 500 mL] to yield five fractions. Fraction 2 [CHCl3/acetone (3:2) 
eluate] was  re-chromatographed by MPLC on silica gel [n-hexane/acetone (2:1) to 
acetone]  followed by HPLC [CHCl3/acetone (15:1)] to give novobenzomalvins A (1: 75 
mg), B (2: 100 mg), and C (3: 21 mg), along with epi-aszonalenins A and C, and helvolic 
acid. The spectral data of all compounds were identical to those in the literature [4–7].  
Novobenzomalvin A  
((7R)-7-benzyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione, 1) 
Colorless amorphous solid; [α]D
20 +136° (c 1.09, MeOH); UV (MeOH) λmax (log ε) 213 (4.4), 
227 (4.4), 269 (3.7), 279 (3.7), 310 (3.4) nm; IR (KBr) νmax 3437, 1690, 1665, 1615, 1597 
cm
−1; CD (0.082 mM, MeOH) λmax (∆ε) 210 (−33.5), 231(14.9), 254 (−5.2), 287 (1.8) nm. 
The 
1H and 
13C NMR data, see Table 1; HRCIMS m/z  [M+H]
+  368.1382 (calcd for 
C23H18N3O2, 368.1372). 944  K. Ishikawa et al.:   
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Novobenzomalvin B  
((7S)-7-[Hydroxy(phenyl)methyl]-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-
dione, 2) 
Colorless prisms (acetone/MeOH); mp 228–231°C; [α]D
20 +26° (c 0.25, MeOH); UV (MeOH) 
λmax (log ε) 218 (4.7), 228 (4.7), 270 (4.0), 280 (4.0), 311 (3.8), 317 (0.3) nm; IR (KBr) νmax 
3420 (br), 1692, 1673, 1614, 1597 cm
−1; CD (0.052 mM, MeOH) λmax (∆ε) 210 (−27.8), 
232 (14.7), 253 (−4.8), 278 (2.9) nm. The 
1H and 
13C NMR data, see Table 1; HMBC (400 
MHz, CDCl3) 1-NH to C-19, H-4 to C-2, C-3, C-5, H-5 to C-3, H-12 to C-10, C-14, C-16, H-
15 to C-11, C-14, C-16, H-19 to C-2, C-18, C-20, C-21, H-20 to C-18, C-19, C-21, C-22, H-
22(26) to C-20, H-23(25) to C-21, H-24 to C-22, C-26. EIMS m/z 383[M]
+ (20), 365 (12), 
277 (92), 249 (100), 234 (39), 220 (27), 192 (16), 174 (15), 130 (27), 77 (57); HREIMS m/z 
[M]
+ 383.1248 (calcd for C23H17N3O3, 383.1270). 
Novobenzomalvin C  
((7S)-7-(Phenylcarbonyl)-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione, 3) 
Colorless amorphous solid; [α]D
20 −256° (c 0.18, MeOH); UV(MeOH) λmax (log ε) 211 (4.5), 
229 (4.5), 281 (3.8), 310 (3.6) nm; IR (KBr) νmax 3437 (br), 1697, 1672, 1615, 1599 cm
−1; 
CD (0.052 mM, MeOH) λmax (∆ε) 212 (0.5), 218 (−0.8), 229 (1.0), 250 (2.2), 296 (−0.3), 
317 (0.2) nm. The 
1H and 
13C NMR data, see Table 1; HMBC (400 MHz, CDCl3) 1-NH to 
C-19, H-4 to C-2, C-3, C-5, H-5 to C-3, H-12 to C-10, C-14, C-16, H-15 to C-11, C-14, C-
16, H-19 to C-2, C-18, C-20, C-21, H-20 to C-18, C-19, C-21, C-22, H-22(26) to C-20, H-
23(25) to C-21, H-24 to C-22, C-26. EIMS m/z 381[M]
+ (73), 105 (100); HREIMS m/z [M]
+ 
381.1094 (calcd for C23H15N3O3, 381.1113). 
Methylation of novobenzomalvin A (1) 
Methyl iodide (2 mL) was added to a solution of 1 (8 mg) and KOH (10 mg) in DMSO 
(2 mL) and the mixture was stirred at room temperature (rt) for 1 h. The reaction mixture 
was added to  H2O (3 mL) and extracted  three times with CHCl3. The obtained CHCl3 
solution was washed several times with H2O. After addition of anhydrous Na2SO4, the 
filtered solution was evaporated in vacuo. The resulting residue (9.1 mg) was purified by 
HPLC [benzene/acetone (18:1)] to give N-methylnovobenzomalvin A (5: 3.8 mg).  
N-Methylnovobenzomalvin A  
((7R)-7-Benzyl-6-methyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione, 5) 
Colorless amorphous solid; [α]D
20 +145° (c 0.19, MeOH); UV(MeOH) λmax (log ε) 212 (4.4), 
229 (4.4), 230 (4.4), 270 (3.9), 309 (3.5) nm; CD (0.079 mM, MeOH) λmax (∆ε) −77.9 (209), 
22.2 (233), −11.6 (255), 8.4 (278), 4.7 (309), 4.0 (322) nm. 
1H NMR (CDCl3, 400 MHz) δ 
8.33 (1H, d, J=7.7 Hz), 7.96 (1H, d, J=7.8 Hz),7.84 (2H, d, J = 4.1 Hz), 7.62 (2H, dd, J = 
6.3, 1.8 Hz), 7.56 (2H, m), 7.27 (4H, m), 7.22 (1H, m), 4.90 (1H, t, J = 7.7 Hz), 3.82 (1H, 
dd, J = 14.6, 7.8 Hz), 3.44 (1H, dd, J = 14.6, 6.9 Hz), 3.11 (3H, s). 
13C NMR (CDCl3, 100 
MHz) δ 167.3 (C-2), 161.2 (C-10), 151.8 (C-18), 145.95 (C-16), 136.7 (C-21), 134.8 (C-
14), 132.9 (C-8), 131.4 (C-6), 130.9 (C-3), 129.9 (C-4), 129.0 (C-22, C-26), 128.95 (C-5), 
128.88 (C-7), 128.7 (C-23, C-25), 127.72 (C-15), 127.68 (C-13), 127.6 (C-12), 126.9 (C-
24), 121.7 (C-11), 58.3 (C-19), 33.2 (C-20), and 27.9 (N-CH3). EIMS m/z 381[M]
+ (33), 290 
(92), 249 (100), 130 (27), 91 (22); HREIMS m/z [M]
+  381.1475 (calcd for C24H19N3O2 
381.1477).   Novobenzomalvins A–C: Fibronectin Expression Regulators from Aspergillus novofumigatus  945 
Sci Pharm. 2011; 79: 937–950 
Total synthesis of novobenzomalvin A (1) 
The total synthesis of novobenzomalvin A (1) was  accomplished  via  triflate-catalyzed 
dehydrative cyclization promoted by microwave irradiation, following the report of Chu et 
al. (Scheme 1) [8].  
Methyl 2-[(2-aminobenzoyl)amino]benzoate (7) 
Anthranilic acid (6: 5 g, 0.024 mol) and isatoic acid (8 g, 0.049 mol) was added to H2O 
(80 mL) at rt, and the mixture was stirred at reflux for 2  h. Then,  the H2O layer was 
evaporated to give a crude residue. The residue was added to a solution of H2SO4/MeOH 
(1:20 v/v, 94.5 mL), and the mixture was stirred at reflux for 2 d. The reaction was 
quenched by the addition of saturated NaHCO3 solution. The aqueous layer was extracted 
with CHCl3. The combined organic layer was evaporated to give a crude residue, which 
was purified by MPLC [benzene/acetone (4:1)] to afford 7 (3.98 g, 62%) as a colorless 
amorphous solid. 
1H-NMR(CDCl3): δ 3.87 (3H, s, N-Me), 6.61 (1H, ddd, J = 8.4, 7.3, 1.3, 
Hz), 6.71 (1H, dd, J = 8.4, 1.3 Hz), 7.06 (1H, dd, J = 8.4, 1.3 Hz), 7.16 (1H, ddd, J = 8.2, 
7.3, 1.5 Hz), 7.51 (1H, ddd, J = 8.5, 7.3, 1.3 Hz), 7.59 (1H, dd, J = 8.5, 1.5 Hz), 8.01 (1H, 
dd, J = 8.2, 1.5 Hz), 8.66 (1H, dd, J = 8.5, 1.3 Hz). 
13C-NMR (CDCl3): δ 52.4, 115.2, 115.6, 
116.9, 117.6, 120.4, 122.3, 127.7, 131.0, 132.9, 134.6, 142.0, 149.9, 168.1, 168.9. 
HREIMS: 270.0979 (M
+), calcd for C15H14N2O3, 270.1004. 
Methyl 2-({[2-({N-[(benzyloxy)carbonyl]-D-phenylalanyl}amino)phenyl]carbonyl}amino)-
benzoate (8-Z)  
A solution of N-[(benzyloxy)carbonyl]-D-phenylalanine (Cbz-D-Phe), 1-ethyl-3-[3-(dimethyl-
amino)propyl)]carbodiimide (EDC) (1.8  g, 9.4 mmol), and N,N-di-iso-propyl-ethylamine 
(DIEA) (2.43 g, 18.8 mmol) in CH2Cl2 (15 mL) was added dropwise to a solution of 7 (507 
mg, 1.88 mmol) in CH2Cl2 (5 mL) at rt, and the mixture was stirred for 5.5 h at rt. The 
reaction was quenched by the addition of saturated NaHCO3 solution. The aqueous layer 
was extracted with CHCl3. The combined organic layer was evaporated to give a crude 
residue, which was purified by MPLC [n-hexane/CHCl3/acetone (2:1:0.4)] to afford 8-Z 
(195 mg, 20%) as a colorless amorphous solid. 
1H NMR (CDCl3): δ 3.06 (1H, dd, J = 14.3, 
7.0 Hz), 3.14 (1H, dd, J = 14.3, 5.7 Hz), 3.78 (3H, s), 4.56 (1H, dd, J = 13.2, 6.6 Hz), 4.95 
(1H, d, J = 12.4 Hz), 5.01 (1H, d, J = 12.4 Hz), 5.58 (1H, m, NH), 6.92-7.00 (2H, m), 7.01-
7.10 (6H, m), 7.11-7.23 (4H, m), 7.29 (1H, dd, J = 7.5, 7.4 Hz), 7.36 (1H, dd, J = 7.8, 7.7 
Hz), 7.69 (1H, d J = 7.8 Hz), 7.92 (1H, d, J = 8.2 Hz), 8.51-8.61 (2H, m), 11.54 (1H, brs, 
NH), 11.86 (1H, brs, NH).
13C NMR (CDCl3): δ 38.3, 52.4, 57.2, 66.8, 115.3, 120.4, 120.6, 
121.3, 122.9, 123.4, 126.7, 126.9, 127.6 (2C), 127.8, 128.3 (2C), 128.4 (2C), 129.1 (2C), 
130.8, 132.8, 134.4, 136.1, 136.2, 139.4, 140.9, 155.7, 167.1, 168.7, 169.7. ESIMS: 574.4 
(M+Na)
+. 
Methyl 2-({[2-(D-phenylalanylamino)phenyl]carbonyl}amino)benzoate (8)  
To a solution of 8-Z (40 mg, 0.073 mmol) in MeOH (2 mL), 20% palladium on carbon 
(Pd/C) was added at rt, the mixture was stirred for 75 min at rt in a hydrogen atmosphere. 
The reaction was filtered and concentrated in vacuo  to give 8  (18.3 mg, 60%). 
1H-
NMR(CDCl3): δ 2.82 (1H, dd, J = 13.7, 9.4 Hz), 3.33 (1H, dd, J = 13.7, 4.1 Hz), 3.77 (1H, 
dd, J = 9.4, 4.1 Hz), 3.95 (3H, s), 7.11-7.32 (8H, m), 7.49-7.64 (3H, m), 7.84 (1H, d, J = 8.0 
Hz), 8.09 (1H, d, J = 8.0 Hz), 8.71 (1H, d, J = 8.4 Hz), 8.79 (1H, d, J = 8.6 Hz), 11.85 (1H, 
brs, NH), 11.91 (1H, brs, NH). ESIMS (%): 440.3 [(M+Na)
+, 100], 418.3 [(M+H)
+, 91]. 946  K. Ishikawa et al.:   
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Synthetic novobenzomalvin A (1) 
To a solution of the 8  (18.3 mg) in DMF (0.5 mL) was added tin(II) trifluoromethane 
sulfonate [Sn(OTf)2] (18.3 mg, 0.044 mmol), and the mixture was treated by microwave 
irradiation at a controlled temperature of 140 °C for 10 min. The reaction was evaporated 
in vacuo, and was purified by HPLC [n-hexane/acetone (2:1)] to afford 1 (13.8 mg, 85%, 
total yield 6.3%) as a colorless amorphous solid. 
Single-crystal X-ray analysis of novobenzomalvin B (2) 
Novobenzomalvin B (2) was grown slowly from acetone/MeOH to give colorless prisms. 
Diffraction intensities were collected from a single crystal having approximate dimensions 
of 0.51 × 0.16 × 0.10 mm on a Rigaku RAXIS RAPID imaging plate area detector with 
graphite  monochromated Cu-Kα  radiation. Of 9116 reflections, 2974 were unique 
reflections. The data were corrected for Lorenz and polarization effects. 
Crystal data 
C23H17N3O3, M= 383.41, monoclinic, space group P21, a= 10.07473 (18), b= 7.80258 (15), 
c= 11.3914 (2) Å, β= 104.4659 (12)°, V = 867.07 (3) Å
3, Z= 2, Dc= 1.468 g⋅cm
−3, F(000)= 
400, μ(Cu-Kα) = 8.109 cm
−1.  
Structure solution and refinement  
The structure was solved by a direct method using SIR92 [12] and expanded using Fourier 
techniques with DIRDIF99 [13] and refined by the full-matrix least-squares method. The 
non-hydrogen atoms were refined anisotropically and hydrogen atoms were refined using 
the riding model. The final cycle of full-matrix least squares refinement on F
2 was based on 
8714 observed reflections and 280 variable parameters. The final R and Rw values were 
0.0337 and 0.0940, respectively. The absolute structure was deduced based on the Flack 
parameter  [11]  −0.04  (12),  refined  using  1263  Friedel  pairs [10].  For more detailed 
information, see Supporting Information available online. 
Oxidation of novobenzomalvin B (2) with PCC 
The CH2Cl2 solution (0.5 mL) of novobenzomalvin B (2: 9 mg) was added to a CH2Cl2 
suspension (1 mL) of PCC (50 mg) and the mixture was refluxed for 29 h with stirring. The 
reaction mixture was filtered, and the filtrate was evaporated in vacuo. The obtained 
residue was purified by LPLC with CHCl3/acetone (15:1) to give novobenzomalvin C (3: 2 
mg). Synthetic 3 was identical to naturally occurring 3 in comparisons of the 
1H, 
13C NMR, 
[α]D
20, HREIMS, UV, CD, TLC, and HPLC data.  
Immunoblotting 
The antibodies used for Western blot analyses including mouse anti-fibronectin antibody 
(BD Bioscience, Franklin Lakes, NJ, USA) and anti-GAPDH antibody (Millipore, Billerica, 
MA, USA).  Horseradish  peroxidase  (HRP)-conjugated anti-mouse and -rabbit IgG (GE 
Healthcare Japan, Tokyo, Japan) were used as secondary antibodies. NHDF-neo cells 
(Takara  Bio  Inc.,  Shiga, Japan) were grown in complete medium: Dulbecco’s modified 
Eagle’s medium (DMEM) (Sigma, MO, USA) supplemented with 10% (v/v) fetal bovine 
serum  (FBS)  (Sigma),  L-glutamine and penicillin/streptomycin (Invitrogen  Co. Ltd, 
Carlsbad, CA, USA). Cells were plated at the density of 5 x 10
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Sci Pharm. 2011; 79: 937–950 
(TPP, MO, USA). After 24 h incubation with serum-free DMEM, cells were treated with 
complete medium containing various compounds. At the end of 24 h incubation, cells were 
washed with cold PBS and lysed on ice in lysis buffer [10 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 1 mM EDTA, 1% NP-40, and protease inhibitor cocktail (Roche Applied Science)]. 
The samples were resolved on 7.5% Tris-Glycine polyacrylamide gels and transferred onto 
polyvinylidene fluoride (PVDF) membrane (Bio-Rad Bioscience; Hercules, CA). The 
membranes were blocked for 1 h in TBS containing 0.05% Tween-20 (TBS-T) and 5% fat-
free milk and then incubated overnight at 4 °C with the primary antibody. The membranes 
were washed with TBS-T four times followed by incubation for 1 h at rt with HRP-
conjugated anti-mouse IgG and the immunoreactivity was assessed by chemi-
luminescence. 
Statistical methods  
Densitometry analysis was performed using ImageJ 1.43 on immunoblots from three 
independent experiments. A t-test was performed with SYSTAT software (Hulinks Inc., 
Tokyo, Japan). 
Antifungal assay  
The antifungal assay was performed by using a previously reported  method  [23]. The 
antifungal assay was performed using the paper disk method against A. niger IFM 41398, 
A. fumigatus IFM 41362, C. albicans IFM 40009 and C. neoformans ATCC 90112 as test 
organisms. Novobenzomalvin A (1) to C (3) were applied to the paper disk (diameter: 8 
mm) at 100 μg/disk, and the disks were placed on the assay plates. The test organisms 
were cultivated in potato dextrose agar (Nissui Pharmaceutical Co., Ltd, Tokyo, Japan) at 
25 °C. After 48–72 h of incubation, zones of inhibition (the diameter measured in 
millimeters) were recorded. 
Cytotoxicity assay 
The cytotoxicity assay was performed by a modified method [23]. Cell were seeded into 
96-well microplates at 4000 cells/well, allowed to attach for 4–6 h and then incubated in 
DMEM (Invitrogen Co. Ltd) for A549 human lung cancer cell and Hela human cervical 
cancer cell, or in RPMI-1640 medium (Wako Pure Chemical Industries, Ltd, Osaka, Japan) 
supplemented with 10% (v/v) FBS, penicillin G (100 U/mL), streptomycin (100 μg/mL) and 
amphotericin B (0.25 μg/mL) for LNCap human prostate adenocarcinoma cells until 80% 
confluence. The media were supplemented with the indicated concentrations of isolated 
compounds for 48–72 h. Cell proliferation was measured with Cell Counting Kit-8 (Dojindo, 
Kumamoto, Japan) to count living cells by combining WST-8 (2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium) and 1-methoxy PMS (1-methoxy-
phenazine methosulfate). Briefly, after the medium was removed, 10 μL of Cell Counting 
Kit-8 solution was added to each well, and the plates were incubated for 4 h, then cell 
numbers were obtained by scanning with a Bio-Rad Model Q4 550 microplate reader at 
450 nm. 
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